| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 24.64▼ | 24.74▼ | 24.74▼ | 24.32▼ | 23.36▲ |
| MA10 | 24.70▼ | 24.82▼ | 24.71▼ | 24.40▼ | 20.00▲ |
| MA20 | 24.81▼ | 24.68▼ | 24.62▼ | 23.66▲ | 14.78▲ |
| MA50 | 24.85▼ | 24.46▼ | 24.44▼ | 19.83▲ | N/A |
| MA100 | 24.68▼ | 23.90▲ | 23.15▲ | 14.40▲ | N/A |
| MA200 | 24.49▼ | 21.21▲ | 19.41▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.048▼ | -0.045▼ | -0.032▼ | -0.288▼ | 1.226▲ |
| RSI | 26.401▼ | 41.905▼ | 46.851▼ | 54.966▲ | 68.607▲ |
| STOCH | 41.896 | 26.633 | 51.194 | 58.250 | 80.677▲ |
| WILL %R | -100.000▼ | -100.000▼ | -85.507▼ | -53.571 | -13.971▲ |
| CCI | -300.417▼ | -161.472▼ | -59.940 | 16.162 | 92.152 |
|
Monday, April 15, 2024 09:49 AM
Biomarker Data Presented at AD/PD 2024. On March 5, 2024, CervoMed Inc. CRVO announced the presentation of biomarker data from the AscenD-LB Phase 2a trial of neflamapimod in pati ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/04/24 | 24.44 | 25.50 | 23.82 | 23.82 | 31,022 |
| 25/04/24 | 25.00 | 25.00 | 24.0097 | 24.99 | 26,007 |
| 24/04/24 | 24.475 | 25.38 | 23.89 | 24.60 | 30,121 |
| 23/04/24 | 24.0718 | 24.95 | 24.00 | 24.29 | 15,734 |
| 22/04/24 | 24.00 | 24.97 | 22.19 | 23.89 | 35,003 |
| 19/04/24 | 25.38 | 25.38 | 23.455 | 24.00 | 11,600 |
| 18/04/24 | 24.71 | 25.25 | 24.2098 | 25.25 | 5,049 |
| 17/04/24 | 24.98 | 25.45 | 24.1027 | 25.00 | 10,702 |
| 16/04/24 | 23.46 | 25.3274 | 23.02 | 24.85 | 9,704 |
| 15/04/24 | 24.52 | 25.92 | 22.00 | 23.35 | 34,718 |
|
|
||||
|
|
||||
|
|